161 related articles for article (PubMed ID: 31740096)
1. Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population.
Zeng W; Horrocks KJ; Tan ACL; Wong CY; Chua BY; Jackson DC
Vaccine; 2020 Jan; 38(3):597-607. PubMed ID: 31740096
[TBL] [Abstract][Full Text] [Related]
2. A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building.
Zeng W; Horrocks KJ; Robevska G; Wong CY; Azzopardi K; Tauschek M; Robins-Browne RM; Jackson DC
J Biol Chem; 2011 Apr; 286(15):12944-51. PubMed ID: 21321114
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a Self-Adjuvanting MUC1 Vaccine via Diselenide-Selenoester Ligation-Deselenization.
McDonald DM; Hanna CC; Ashhurst AS; Corcilius L; Byrne SN; Payne RJ
ACS Chem Biol; 2018 Dec; 13(12):3279-3285. PubMed ID: 30359529
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.
Zaman M; Abdel-Aal AB; Fujita Y; Ziora ZM; Batzloff MR; Good MF; Toth I
J Med Chem; 2012 Oct; 55(19):8515-23. PubMed ID: 22974133
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates.
McDonald DM; Wilkinson BL; Corcilius L; Thaysen-Andersen M; Byrne SN; Payne RJ
Chem Commun (Camb); 2014 Sep; 50(71):10273-6. PubMed ID: 25056269
[TBL] [Abstract][Full Text] [Related]
6. A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli.
Zeng W; Azzopardi K; Hocking D; Wong CY; Robevska G; Tauschek M; Robins-Browne RM; Jackson DC
Vaccine; 2012 Jul; 30(32):4800-6. PubMed ID: 22634295
[TBL] [Abstract][Full Text] [Related]
7. Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant.
Azmi F; Ahmad Fuaad AA; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
Bioorg Med Chem; 2014 Nov; 22(22):6401-8. PubMed ID: 25438764
[TBL] [Abstract][Full Text] [Related]
8. Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.
Abdel-Aal AB; Zaman M; Fujita Y; Batzloff MR; Good MF; Toth I
J Med Chem; 2010 Nov; 53(22):8041-6. PubMed ID: 21028828
[TBL] [Abstract][Full Text] [Related]
9. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate.
Zeng W; Tan AC; Horrocks K; Jackson DC
Vaccine; 2015 Jul; 33(30):3526-32. PubMed ID: 26049002
[TBL] [Abstract][Full Text] [Related]
10. Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: influence of different chemical linkages and epitope orientations on biological activity.
Zeng W; Ghosh S; Macris M; Pagnon J; Jackson DC
Vaccine; 2001 Jul; 19(28-29):3843-52. PubMed ID: 11427256
[TBL] [Abstract][Full Text] [Related]
11. Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.
Cai H; Sun ZY; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2013 Feb; 19(6):1962-70. PubMed ID: 23280874
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.
Nevagi RJ; Dai W; Khalil ZG; Hussein WM; Capon RJ; Skwarczynski M; Toth I
Eur J Med Chem; 2019 Oct; 179():100-108. PubMed ID: 31247372
[TBL] [Abstract][Full Text] [Related]
13. Active immunisation of mice with GnRH lipopeptide vaccine candidates: Importance of T helper or multi-dimer GnRH epitope.
Goodwin D; Simerska P; Chang CH; Mansfeld FM; Varamini P; D'Occhio MJ; Toth I
Bioorg Med Chem; 2014 Sep; 22(17):4848-54. PubMed ID: 25059504
[TBL] [Abstract][Full Text] [Related]
14. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte response induced by an improved synthetic lipopeptide vaccine against cervical cancer.
Xu DH; Zhou CH; Xia YP; Qiu ZY; Wu YZ; Jia ZC; Zhou W
Acta Pharmacol Sin; 2007 May; 28(5):695-702. PubMed ID: 17439726
[TBL] [Abstract][Full Text] [Related]
16. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
[TBL] [Abstract][Full Text] [Related]
17. Peptide-free Synthetic Nicotine Vaccine Candidates with α-Galactosylceramide as Adjuvant.
Chen XZ; Zhang RY; Wang XF; Yin XG; Wang J; Wang YC; Liu X; Du JJ; Liu Z; Guo J
Mol Pharm; 2019 Apr; 16(4):1467-1476. PubMed ID: 30821985
[TBL] [Abstract][Full Text] [Related]
18. Self-adjuvanting lipopeptide vaccines.
Moyle PM; Toth I
Curr Med Chem; 2008; 15(5):506-16. PubMed ID: 18289006
[TBL] [Abstract][Full Text] [Related]
19. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.
Chen J; Pompano RR; Santiago FW; Maillat L; Sciammas R; Sun T; Han H; Topham DJ; Chong AS; Collier JH
Biomaterials; 2013 Nov; 34(34):8776-85. PubMed ID: 23953841
[TBL] [Abstract][Full Text] [Related]
20. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.
Zeng W; Ghosh S; Lau YF; Brown LE; Jackson DC
J Immunol; 2002 Nov; 169(9):4905-12. PubMed ID: 12391202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]